Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Nie, Huizhen ^a   Cao, Qingzhen ^a   Zhu, Lei ^a   Gong, Yuehua ^b   Gu, Jianren ^a   He, Zuping ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANDROGEN RECEPTOR; BICALUTAMIDE; METRIBOLONE; PROTEIN KINASE B; STAT3 PROTEIN;

ANDROGEN RECEPTOR GENE; APOPTOSIS; ARTICLE; CANCER INVASION; CELL FATE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UPREGULATION; WESTERN BLOTTING;

ACETYLCHOLINE; ANDROGEN ANTAGONISTS; ANDROGENS; ANILIDES; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MECAMYLAMINE; METRIBOLONE; NEOPLASM INVASIVENESS; NITRILES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; RECEPTORS, CHOLINERGIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOSYL COMPOUNDS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84876440523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061678     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. De Maria N, Manno M, Villa E, (2002) Sex hormones and liver cancer. Mol Cell Endocrinol 193: 59-63.
3. Ma WL, Hsu CL, Wu MH, Wu CT, Wu CC, et al. (2008) Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135: 947-955.
4. Ao J, Meng J, Zhu L, Nie H, Yang C, et al. (2012) Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol 6: 507-515.
5. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
6. Ramachandran B, Stell A, Maravigna L, Maggi A, Ciana P, (2011) Novel insights on imaging sex-hormone-dependent tumourigenesis in vivo. Endocr Relat Cancer 18: R41-51.
7. Zhao Y, Wang X, Wang T, Hu X, Hui X, et al. (2011) Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Hepatology 53: 493-503.
8. He Z, Jiang J, Kokkinaki M, Golestaneh N, Hofmann MC, et al. (2008) Gdnf upregulates c-Fos transcription via the Ras/Erk1/2 pathway to promote mouse spermatogonial stem cell proliferation. Stem Cells 26: 266-278.
9. He Z, Jiang J, Kokkinaki M, Dym M, (2009) Nodal signaling via an autocrine pathway promotes proliferation of mouse spermatogonial stem/progenitor cells through Smad2/3 and Oct-4 activation. Stem Cells 27: 2580-2590.
10. O'Neill MJ, Murray TK, Lakics V, Visanji NP, Duty S, (2002) The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Targets CNS Neurol Disord 1: 399-411.
11. Bubser M, Byun N, Wood MR, Jones CK, (2012) Muscarinic receptor pharmacology and circuitry for the modulation of cognition. Handb Exp Pharmacol 208: 121-166.
12. Improgo MR, Tapper AR, Gardner PD, (2011) Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol 82: 1015-1021.
13. Schuller HM, (2009) Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9: 195-205.
14. Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, et al. (2012) Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene doi: 10.1038/onc.2012.425. [Epub ahead of print].
15. Bailey ST, Shin H, Westerling T, Liu XS, Brown M, (2012) Estrogen receptor prevents p53-dependent apoptosis in breast cancer. Proc Natl Acad Sci U S A 109: 18060-18065.
16. Yeh SH, Chen PJ, (2010) Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78Suppl 1: 172-179.
17. Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, et al. (2012) Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology 56: 176-185.
18. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, et al. (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci U S A 96: 5458-5463.
19. Ueda T, Bruchovsky N, Sadar MD, (2002) Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 277: 7076-7085.
20. Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, et al. (2000) HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res 60: 6841-6845.
21. Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, et al. (2001) Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Biochem Biophys Res Commun 283: 179-187.
22. Yamamoto T, Sato N, Sekine Y, Yumioka T, Imoto S, et al. (2003) Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor. Biochem Biophys Res Commun 306: 610-615.
23. Chen RJ, Ho YS, Guo HR, Wang YJ, (2008) Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells. Toxicol Sci 104: 283-293.